Skip to main content
Log in

QOL not reduced in elderly receiving adjuvant chemotherapy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. IV cisplatin 80 mg/m2 on day 1 plus vinorelbine 25 mg/m2 on days 1 and 8 or IV paclitaxel 175 mg/m2 plus carboplatin area under the curve of 5.5 on day 1, at 3-week intervals.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

QOL not reduced in elderly receiving adjuvant chemotherapy. PharmacoEcon Outcomes News 673, 10 (2013). https://doi.org/10.1007/s40274-013-0218-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0218-8

Navigation